Which hedge funds own MDGL? MADRIGAL PHARMACEUTICALS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
12 of the hedge funds tracked by WhaleCreep disclosed a position in MDGL (MADRIGAL PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $673.3m in total. The largest holder by portfolio weight is Woodline Partners at 0.2% of its book. 2 managers opened a new position this quarter: Holocene Advisors, Brevan Howard Capital Management. 2 exited: Bridgewater Associates, Farallon Capital Management.
12tracked managers holding
2opened this quarter
2exited this quarter
Which hedge funds hold MDGL? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Woodline Partners | Q2 2026 | 0.2% | $67.6m | 125,899 | 0% | held |
| Holocene Advisors | Q2 2026 | 0.2% | $82.1m | 152,924 | – | new |
| Citadel Advisors | Q2 2026 | 0.2% | $272.4m | 507,233 | 12% | added |
| Point72 Asset Management LP | Q2 2026 | 0.1% | $73.6m | 137,029 | -39% | reduced |
| Alkeon Capital Management | Q2 2026 | 0.1% | $14.1m | 80,000 | 0% | held |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $3.5m | 6,447 | – | new |
| Marshall Wace | Q2 2026 | 0.0% | $54.7m | 101,859 | 365% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $24.7m | 45,942 | -36% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $43.6m | 81,196 | 99% | added |
| Tudor Investment | Q2 2026 | 0.0% | $6.2m | 11,509 | -1% | reduced |
| WCM Investment Management | Q2 2026 | 0.0% | $12.1m | 22,985 | -2% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $18.8m | 35,071 | 16% | added |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Bridgewater Associates | 0.3% | $2.1m |
| Farallon Capital Management | 0.1% | $1.7m |
How has hedge fund ownership of MDGL changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 12 | $673.3m |
| Q1 2026 | 12 | $599.6m |
| Q4 2025 | 9 | $469.8m |
| Q3 2025 | 9 | $176.5m |
| Q2 2025 | 5 | $91.9m |
| Q1 2025 | 5 | $285.6m |
| Q4 2024 | 4 | $149.2m |
| Q3 2024 | 3 | $41.4m |
| Q2 2024 | 3 | $51.2m |
| Q1 2024 | 7 | $88.2m |
| Q4 2023 | 2 | $48.1m |
| Q3 2023 | 5 | $66.2m |
| Q2 2023 | 3 | $19.7m |
| Q1 2023 | 5 | $89.2m |
| Q4 2022 | 5 | $173.5m |
| Q3 2022 | 3 | $3.2m |
Counts every tracked manager that disclosed MDGL in that quarter's filing, including managers that have since stopped filing.